Print this page    •   Back to Web version of article

Medical News
Australia: Biotron Anti-HIV Compounds Shown to Act Against HIV

August 23, 2005

The Australian biotechnology firm Biotron Ltd. said recently that its Virion compound was found to work against drug-resistant HIV. CEO Michelle Miller said the treatment worked at later stages than all major HIV drugs currently on the market by preventing infectious viruses from coming outside of the cells. In addition, the compound works against multidrug-resistant HIV, said Miller. Final safety studies are being performed on Virion, and Biotron anticipates "proof of concept" trials -- required for regulatory approval -- by the end of this year. Biotron, which commercializes research out of John Curtain School of Medical Research and the Australian National University in Canberra, said it plans to partner with a major pharmaceutical firm within the next year.

Back to other news for August 23, 2005

Excerpted from:
Australian Associated Press
08.17.05




This article was provided by CDC National Prevention Information Network. It is a part of the publication CDC HIV/Hepatitis/STD/TB Prevention News Update. You can find this article online by typing this address into your Web browser:
http://www.thebody.com/content/art25683.html

General Disclaimer: TheBody.com is designed for educational purposes only and is not engaged in rendering medical advice or professional services. The information provided through TheBody.com should not be used for diagnosing or treating a health problem or a disease. It is not a substitute for professional care. If you have or suspect you may have a health problem, consult your health care provider.